EUVIMEDEUVIMED entdecken
Open Access

FAT10 Silencing Prevents Liver Fibrosis through Regulating SIRT1 Expression in Hepatic Stellate Cells

Weihong Zheng, Fei Guan, Guoxing Xu, Yikai Yu, Jun Xiao, Xiaowei Huang

International Journal of Medical Sciences · 2023

DOI: 10.7150/ijms.77367 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2023. Verfasst von Weihong Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Sirtuin 1, Ubiquitins. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives: Hepatic stellate cell (HSC) activation is the cardinal factor due to the accumulation of extracellular matrix proteins during the development of liver fibrosis. The aim of the present study was to find new targets for developing drugs to treat liver fibrosis, by screening the key genes involved in the activation of hepatic stellate cells.

Methods

Differentially expressed genes were identified through TCGA database. RT-PCR, immunohistochemistry (IHC) assay, western blot, and ELISA were performed to evaluate the expression levels of FAT10 and fibrotic molecules. In vitro experiments were conducted to investigate the signaling pathways and biological functions of FAT10 in LX-2 cell lines.

Results

In the present study, expression profiles obtained from the Gene Expression Omnibus (GEO) were used to explore the different genes expression between HSCs treated with or without carbon tetrachloride (CCl4). Human leukocyte antigen (HLA)-F adjacent transcript 10 (FAT10) was selected for further investigations. In animal model of carbon tetrachloride-induced liver fibrosis, the expression of FAT10 on activated HSCs is upregulated. In vitro, silencing FAT10 reduced TGF-β1-induced ECM activation and accumulation in LX-2 cells, and also suppressed the inflammatory response of LX-2 cells. Further Transwell results suggested that knockdown of FAT10 could inhibit TGF-β1-induced LX-2 cell migration and invasion. Mechanistically, FAT10 promotes its fibrotic activity through regulating sirtuin 1 (SIRT1), with a concomitant activation of ECM.

Conclusions

These findings indicated an unexpected role of FAT10 in liver fibrosis development, suggesting that silencing FAT10 might represent a new strategy for the treatment of fibrotic liver diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatic Stellate CellsSirtuin 1UbiquitinsAnimalsHumansCarbon TetrachlorideFibrosisLiver CirrhosisTransforming Growth Factor beta1

Stichwörter der Autor:innen

FAT10SIRT1hepatic stellate cellsinflammationliver fibrosis

Substanzen

Carbon TetrachlorideSIRT1 protein, humanSirtuin 1Transforming Growth Factor beta1UBD protein, humanUbiquitins

Autor:innen und Institutionen

  • Department of General Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Department of Respiratory and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430010, China.
  • Department of Rheumatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Department of Gastroenterology and Hepatology, Huangzhou District People's Hospital, Huanggang 438000, China.
  • Department of Gastroenterology and Hepatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

Zitieren

APA

Zheng, W., Guan, F., Xu, G., Yu, Y., Xiao, J., & Huang, X. (2023). FAT10 Silencing Prevents Liver Fibrosis through Regulating SIRT1 Expression in Hepatic Stellate Cells. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.77367

Vancouver

Zheng W, Guan F, Xu G, Yu Y, Xiao J, Huang X. FAT10 Silencing Prevents Liver Fibrosis through Regulating SIRT1 Expression in Hepatic Stellate Cells. International Journal of Medical Sciences. 2023. doi:10.7150/ijms.77367

BibTeX
@article{Zheng2023,
  author = {Zheng, Weihong and Guan, Fei and Xu, Guoxing and Yu, Yikai and Xiao, Jun and Huang, Xiaowei},
  title = {FAT10 Silencing Prevents Liver Fibrosis through Regulating SIRT1 Expression in Hepatic Stellate Cells},
  journal = {International Journal of Medical Sciences},
  year = {2023},
  doi = {10.7150/ijms.77367}
}
Kostenlos starten →